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Endothelin-1 induction of cyclooxygenase.2 expression in rat mesangial
cells. Prostaglandin E2 (POE2) may be an important negative feedback
modulator of endothelin-1 (ET-1)-stimulated mesangial cell proliferation
and contraction. Recent studies suggest that ET-1 may induce prolonged
mesangial cell POE2 production, however the mechanism of this effect is
unknown. The current study was undertaken, therefore, to examine the
long-term effect of ET-1 on mesangial cell POE2 synthesis. ET-1 markedly
increased POE2 release by rat mesangial cells for at least six hours.
Cyclooxygenase (COX) activity was increased by one hour and persisted
for at least six hours. ET-1 increased COX-2, but not COX-1, protein and
mRNA levels. Actinomycin D reduced ET-1-stimulated PGE2 synthesis
and COX-2 mRNA expression, while cycloheximide superinduced COX-2
mRNA. Dexamethasone decreased ET-1-stimulated PGE2 release and
COX-2 protein and mRNA levels. ET-1-stimulated PGE2 release was
prevented by BQ-123, an endothelin receptor A antagonist. We conclude
that ET-1, via activation of the endothelin A receptor, causes a prolonged
increase in mesangial cell PGE2 production that is partially dependent on
induction of dexamethasone-inhibitable COX-2.
Endothelin-l (ET-1) is a 21-amino acid peptide that exerts an
extremely broad range of biologic effects on virtually every organ
system. Of these target tissues, the kidney, by virtue of high ET-1
production, high ET-1 receptor expression, and uniquely high
sensitivity to ET-1, has emerged as a major site of ET-1 action [1].
Among the various cells in the kidney, the glomerular mesangial
cell has been the subject of particularly intensive investigation into
the physiologic and pathophysiologic effects of ET-1. Mesangial
cells secrete ET-1 constitutively and in response to inflammatory
cytokines [2], express endothelin receptors [3], and respond to
picomolar amounts of the peptide [4]. ET-1 causes mesangial cells
to contract, proliferate, and produce platelet-derived growth
factor, collagenase and fibronectin [4—8]. These observations
have led to the hypothesis that ET-1 plays an important role in
glomerular pathophysiology as well as normal physiology. For
example, ET-1 has been implicated in the reduced glomerular
filtration rate that occurs in the settings of acute ischemic renal
failure and acute cyclosporine nephrotoxicity [9, 10]. In addition,
since mesangial cell proliferation is a common component of
glomerular inflammation and since glomerular ET-1 levels are
increased in experimental glomerulonephritis, ET-1 has been
proposed to be of pathogenic importance in proliferative glomer-
ular diseases [11].
The cellular events accompanying ET-1 receptor activation in
mesangial cells have been examined in some detail. ET-1 binding
to mesangial cells activates numerous signal transduction systems
[4, 7, 12, 13]. Of these second messengers, the ability of ET-1 to
increase arachidonate metabolites may be of particular impor-
tance. While it remains controversial as to the nature of all
eicosanoids produced, it appears that ET-1 stimulates mesangial
cells to produce relatively large amounts of prostaglandin E2
(PGE2) [13, 14]. Several studies have shown that vasorelaxant
prostanoids serve as negative feedback modulators of ET-1-
induced cell contraction. For example, ET-1-induced mesangial
cell contraction is attenuated by POE2 [14], while cyclooxygenase
inhibition increases the severity of renal vasoconstriction follow-
ing ET-1 administration [15]. ET-1 stimulation of mesangial cell
POE2 production might also modulate mitogenesis and extracel-
lular matrix production since PGE2 inhibits collagen production
and proliferation by mesangial cells [16].
Because the physiological effects of ET-1 can last for several
hours, it is of particular interest that the peptide has been
reported to cause sustained elevations in mesangial cell PGE2
production [13]. The mechanism(s) responsible for such sustained
induction of PGE2 synthesis are uncertain; however, recent
studies raise the possibility that induction of a recently described
cyclooxygenase may be involved, cyclooxygenase-2 (COX-2). Cy-
clooxygenase-1 (COX-1) is constitutively expressed by many cell
types. Its synthesis can be induced by several cytokines, albeit
often to a modest degree [17]. In contrast, COX-2 belongs to the
family of early response genes and is primarily inducible [18, 19].
Indeed, the different patterns of COX-1 and COX-2 synthesis
suggest that they may mediate varying biologic functions. To date,
however, nothing is known about ET-1 effects specifically on
COX-1 or COX-2 in any cell type. Hence, the present study was
undertaken to characterize the sustained increase in mesangial
cell PGE2 production in response to ET-1 and the associated
changes in COX-1 and COX-2 expression.
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Sprague-Dawley rats weighing 150 to 200 g were purchased
from Ellis and Pritchard (American Fork, Utah, USA). Collage-
nase was from Worthington Diagnostics Systems (Freehold, New
Jersey, USA); ET-1 was from Peninsula Laboratories (Belmont,
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CA, USA); RNasin was from Promega (Madison, WI, USA);
Moloney Murine Leukemia Virus reverse transcriptase and Taq
polymerase was from Gibco BRL (Grand Island, NY, USA);
random hexamers were from Boehringer-Mannheim (Indianapo-
lis, IN, USA); dNTPs were from LKB-Pharmacia (Piscataway, NJ,
USA); and 32P-dCTP was from Amersham (Arlington Heights,
IL, USA). Oligonucleotide primers for rat COX-1, COX-2 and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were syn-
thesized by Dr. Robert Schackmann at the University of Utah. All
other chemicals and reagents used were from Sigma Chemical Co.
(St. Louis, MO, USA) unless otherwise stated.
Cell culture
Mesangial cells were isolated from rats as previously described
[20]. Briefly, glomeruli were obtained using 60, 100, and 200 mesh
sieves, incubated in 750 U/ml collagenase (type IV) and 0.01%
deoxyribonuclease (type I, Sigma) for 30 minutes at 37°C. Di-
gested glomeruli were washed twice and cultured in RPMI-1640
containing 20% bovine calf serum (BCS) and insulin (0.5 U/ml) at
37°C in a 5% CO2 incubator. Cultures were studied at confluence
in 6- or 24-well plates (Costar, Pleasonton, CA, USA) between
passages 5 and 10; 99% of cells were positive by immunofluores-
cence for smooth muscle myosin.
PGE2 release studies
Mesangial cells were grown to confluence in the presence of
RPMI + insulin + 20% BCS and studied either immediately
(cycling cells) or after three days exposure to RPM! without
insulin or BCS (growth-arrested cells). The ability of this latter
procedure to render mesangial cells G0 has been well documented
[211. All studies were performed at 37°C in a 5% CO2 incubator.
For time course and dose-response studies, cycling and growth-
arrested cells were incubated in RPMI in the presence and
absence of ET-1 (10 M to 100 nM)for 15 minutes to six hours. For
ET receptor subtype studies, growth-arrested mesangial cells were
incubated in RPMI with and without 10 nrvi ET-1 in the presence
or absence of 1 LM BQ123 (selective endothelin receptor A
subtype A inhibitor [221) for 15 minutes or six hours.
For studies on dexamethasone regulation of ET-1 action,
growth-arrested mesangial cells were pre-incubated for two hours
in either RPM! alone or RPMI containing 2 LM dexamethasone.
Subsequently, the media was changed to RPMI with and without
2 M dexamethasone and in the presence or absence of 10 flM
ET-1 and incubated for 15 minutes to six hours. For studies on
cycloheximide or actinomycin-D regulation of ET-1 action,
growth-arrested mesangial cells were pre-incubated for 15 min-
utes in either RPMI alone or RPM! containing 10 jtg/ml cyclo-
heximide or 1 jtg/ml actinomycin-D. Subsequently, the media was
changed to RPMI with and without 10 g/ml cycloheximide or 1
g/ml actinomycin-D and in the presence or absence of 10 nvi
ET-1 for 15 minutes to six hours. Only growth-arrested cells were
used for dexamethasone, cycloheximide and actinomycin-D stud-
ies; all of these agents alter the effect of serum on PGE2 synthesis
and cyclooxygenase mRNA in mesangial cells [71, thereby poten-
tially confusing interpretation of how ET-1 actions are influenced.
At the end of the incubations, a 50 j.d aliquot was removed from
the cell supernatant and PGE2 assayed by a commercially avail-
able radioimmunoassay (Amersham). Total cell protein was mea-
sured in each well by mixing an aliquot of solubilized mesangial
cells in 0.1 N NaOH with Bradford reagent and absorbance at 650
nm determined [23]. All results are expressed as pg PGE2/ig total
cell protein.
Determination of cyclooxygenase activity
Growth-arrested cells were incubated with RPMI alone or
containing 10 nM ET-1 for up to 6 hours. The cells were then
rinsed and 10 tM arachidonic acid in RPMI added for 15 minutes.
In preliminary studies using 1 to 100 .tM arachidonic acid, it was
determined that 10 tM arachidonic acid caused maximal PGE2
production. At the end of the 15 minute incubation with saturat-
ing concentrations of arachidonic acid, media PGE2 content and
total cell protein were determined as described above.
Determination of relative levels of COX-1 and COX-2 protein
Growth-arrested mesangial cells were pre-incubated for two
hours with RPMI alone or containing 2 M dexamethasone. ET-1
(10 nM) was then added to half the wells pre-incubated with RPMI
alone or containing dexamethasone for up to six hours. The cells
were then lysed in ice-cold buffer (20 mM Tris-HCI (pH 7.5), 16
mM CHAPS, 1 mrvi EDTA, 0.5 mrvt dithiothreitol, 1 mM benzami-
dine hydrochloride, 1 jtg/ml leupeptin, 10 g/ml soybean trypsin
inhibitor) for 30 minutes. The samples were centrifuged for five
minutes at 10,000 X g at 4°C and the protein concentration in the
supernatant determined using a microbicinchoninic acid assay
(Pierce). An aliquot containing the same amount of protein was
taken from the supernatants of each sample and mixed with
loading buffer (125 m'vi Tris-HC1 pH 6.8, 1% SDS, 5% glycerol,
10% 2-mercaptoethanol, and bromophenol blue) and heated at
85°C for 10 minutes before loading on an acrylamide gel (10% and
3% loading and stacking, respectively). Samples were electropho-
resed and transferred onto Hybond-ECL nitrocellulose mem-
branes (Amersham) using a Hoefer Scientific Instruments TE
52X Transphor Electrophoresis Unit. To minimize non-specific
binding, blots were blocked overnight at 4°C in TBST (50 mrvi
Tris-HCI, pH 7.5, 250 mrvi NaCl, 0.1% Tween 20) plus 5% nonfat
dry milk, and 1% normal serum of the species that the secondary
antibody was raised in. To detect COX-2, a polyclonal antibody
raised against a synthetic polypeptide of the unique 18 amino acid
sequence near the C-terminus of the human form of the enzyme
[241 was diluted 250:1 in blocking buffer and incubated with the
membrane for four hours at room temperature. The membrane
was washed four times in blocking buffer, and twice in TBST
alone. Donkey anti-rabbit IgG linked to horseradish peroxidase
was diluted 1000:1 in TBST and incubated with the membrane for
one hour at room temperature. The membrane was washed
extensively in TBST before detecting the bands by chemilumines-
ence following the manufacturer's directions (Amersham). The
membrane was then stripped by incubating in 62.5 mM Tris-HC1
(pH 6.7), 100 mrvi 2-mercaptoethanol, and 2% SDS at 50°C for
one hour. After washing in TBST, the membrane was blocked as
before. To detect COX-1, a monoclonal antibody prepared
against ram seminal vesicle COX-1 [241 was diluted 10,000:1 in
blocking buffer and incubated for one hour at room temperature.
The remainder of the detection process was identical to that for
COX-2 with the exception of using a horseradish peroxidase
linked sheep anti-mouse secondary antibody.
Determination of relative amounts of COX-1, COX-2 and
GAPDH mRNA
Confluent cultures of growth-arrested mesangial cells were
exposed to RPM! alone, 10 nM ET-1, 2 LM dexamethasone, or 10
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g/ml cycloheximide for 15 minutes, 1, 2 or six hours in a manner
identical to that described under measurement of PGE2 produc-
tion above. At the end of the incubation, cells were overlaid with
4 M guanidinium thiocyanate and RNA phenol/chloroform ex-
tracted, precipitated in isopropanol, and resuspended in Tris-
EDTA buffer. Each sample was quantified spectrophotometri-
cally. Five g of total RNA from each sample was reverse
transcribed using 250 pmol random hexamers, 3 m'vi MgC12, 80 U
RNasin, 400 U murine Moloney Leukemia Virus reverse tran-
scriptase, 500 jtM dNTP, 0.01 mM dithiothreitol, 75 mrvi KC1, and
50 mM Tris-Cl (final pH 8.3, final volume 50 pi) for one hour at
37°C. The sample was then heated at 94°C for 10 minutes to
deactivate the enzymes. The cDNA was amplified by polymerase
chain reaction. Each sample was measured for COX-1, COX-2
and GAPDH cDNA in separate tubes using specific primers. The
upstream and downstream primers for COX 1 were 5'-CTGCAT-
GTGGCTGTGGATGTCATC-3' and 5 '-AGGACCCGTCATC-
TCCAGGGTAATC-3', respectively. These yielded a single band
corresponding to a 441 base pair fragment. The sequence for the
441 bp fragment was analyzed by Margaret Robinson in Dr. Ray
White's laboratory at the University of Utah using cycle sequenc-
ing with fluoresceinated primer ends. Analysis of the sequence
revealed that it was identical to position 1374-1815 in mouse
COX-1 cDNA [25]. The upstream and downstream COX-1
primers have 46% and 25% homology with mouse COX-2 cDNA
[25, 26]. PCR of rat genomic DNA with the primers for COX-1
yielded a single product of about 2 kB, indicating that this primer
set spans an intron. The upstream and downstream primers for
COX-2 were 5'-CAAGCAGTGGCAAAGGCCTCCATT-3' and
5'-TAGTCT'GGAGTGGGAGGCACTTGC-3', respectively, which
yielded a single band corresponding to a 473 base pair cDNA
fragment. Analysis of the sequence using cycle sequencing re-
vealed that it was identical to position 1415-1888 in mouse COX-2
cDNA [261. The upstream and downstream COX-2 primers have
46% and 0% homology with mouse COX-1 cDNA [25, 26]. PCR
of rat genomic DNA with the primers for COX-2 yielded a single
product of about 850 bp, indicating that this primer set spans an
intron. The upstream and downstream GAPDH primers were
5'-GTGAAGGTCGGTGTCAACGGATFT-3' and 5 '-CACAG-
TCTTCTGAGTGGCAGTGAT-3', respectively, which yielded a
single band corresponding to a 558 base pair cDNA fragment.
Analysis of the sequence using cycle sequencing revealed that it
was identical to position 3-561 in rat GAPDH eDNA [27].
PCR was performed by incubating sample eDNA with 50 mrvt
KC1, 10 mM Tris-Cl, 0.01% gelatin, 1.5 mM MgCI2, 2.5% form-
amide, 2 U Taq polymerase, 200 jiM dNTP, 100 pmoles of
primers, and 0.15 jiCi 32P-dCTP in 50 pi final volume (final pH
8.3 at room temperature). PCR using GAPDH primers was
carried out for 30 cycles (20 seconds at 94°C, 20 seconds at 65°C,
45 seconds at 72°C) using a Perkin-Elmer Cetus 9600 Gene-Amp
System. PCR using COX-1 or COX-2 primers was carried out for
30 cycles under identical conditions. COX-1, COX-2 or GAPDH
primers were never combined in the same tube. Twenty jil of the
final PCR reaction was electrophoresed using an 8% acrylamide
gel in lx Tris-borate-EDTA buffer. Gels were stained with 1
jig/ml ethidium bromide, the bands corresponding to the eDNA
product excised, mixed with scintillation cocktail, and cpm deter-
mined on a Beckmann beta counter.
COX-1, COX-2 and GAPDH eDNA obtained from PCR of
reverse transcribed RNA were used to generate standard curves,
The eDNA was amplified by PCR, the resultant amplified product
divided into small fractions that were, in turn, re-amplified. The
purity of the final product was confirmed by electrophoresis. If a
single band of the appropriate size was obtained, the final product
was cleaned using Magic PCR Prep (Promega, Madison, WI,
USA) in order to remove the primers. The cleaned product was
again electrophoresed to confirm that it contained only the
desired eDNA. If pure, the eDNA was quantitated spectrophoto-
metrically. Standard curves for COX-1, COX-2 and GAPDH were
made by simultaneously amplifying sample eDNA and, in separate
tubes, standard eDNA (101 to 10—8 ng/tube). Every PCR
amplification included a standard curve. All PCR consisted of
simultaneous amplification (in separate tubes) of eDNA for
COX-1, COX-2 and GAPDH. All results are expressed as fg
COX-1 or COX-2 eDNA/pg GAPDH eDNA in order to control
for the amount of RNA initially reverse transcribed. The accuracy
of this quantitative PCR technique has been previously described
[28]. In brief, three separate reverse transcriptions of the same
RNA sample, followed by PCR of the resultant eDNA (comparing
to the same standard curves), yielded no more than a 5% variation
in measured sample eDNA; the ratio of COX-1 or COX-2 to
GAPDH varied by not more than 6%. In the second control, the
reproducibility of quantitation of eDNA was evaluated. Three
separate PCR amplifications, each using independently made
standard curves, were performed on the same sample of eDNA.
The calculated amount of COX-1, COX-2 or GAPDH eDNA
varied by no more than 16%, while the ratio of ET-1 to B-actin
eDNA varied by 11%. Standard curves using 0.1 to 100 pg of
GAPDH eDNA (which encompasses all sample values) gave
correlation coefficients invariably greater than 0.98. Similarly,
standard curves using 0.1 to 100 fg of COX-1 or COX-2 (which
encompasses all sample values) gave correlation coefficients in-
variably greater than 0,98.
Statistical analysis
All data were analyzed by analysis of variance. Statistical
significance was taken as P < 0.05. Values are presented as mean
standard error of the mean.
Results
Since basal and agonist-stimulated cyclooxygenase activity in
cultured rat mesangial cells may be affected by the growth state of
the cells [21], the effect of ET-1 on randomly cycling and
growth-arrested cells was assessed first. As shown in Figure 1,
ET-1 greatly enhanced PGE2 release by both cycling and growth-
arrested cells. As has been previously reported for other agonists,
the magnitude of ET-1 stimulation of PGE2 release was greater in
cycling than in growth-arrested mesangial cells [21]. Regardless of
the growth state of the cells, ET-1 increased PGE2 release after
only 15 minutes of exposure and continued to stimulate PGE2
production even after six hours of exposure to the peptide. Hence,
it appears that, at least qualitatively, ET-1 stimulation of mesang-
ial cell PGE2 release does not depend on the growth state of the
cells. Further, these studies indicate that ET-l causes a prolonged
increase in PGE2 release by rat mesangial cells. Lastly, it should
be noted that we often observed a large variability in the
magnitude of both basal and ET-1-stimulated PGE2 accumulation
at the various time points studied, although ET-1 always had a
marked stimulatory effect. These differences were manifest not
only between cells at different passage numbers, but also between
Time, hours
Fig. 1. Effect of ET-1 on PGE2 release by cycling (A) and growth-arrested(B) cultured rat mesangial cells. Cells were incubated with 10 nM ET-1 for
15 minutes to 6 hr followed by determination of PGE2 levels in the cell
supernatant. N = 8 per data point; * P < 0.001 vs. basal PGE2 release at
the same time point. Symbols are: (0) basal; (S) ET-1.
plates of cells from the same passage number. The reasons for this
variability are unknown; however, we have noticed that slight
physical perturbation of cultured cells can release PGE2 (unpub-
lished observations). Consequently, all data in this study were
analyzed by comparing controls and treated cells within the same
multiwell plate.
The finding that ET-1 increased POE2 release at both early (15
mm) and late (1 to 6 hr) time points raised the question whether
the same receptor was mediating these effects. As shown in Figure
2, the dose-response curve for ET-1 stimulation of PGE2 release
log [ET-1]
Fig. 2. Dose response of ET-1 stimulation of PGE2 release by growth-
arrested cultured rat mesangial cells. Cells were exposed to 100 nM - 10 M
ET-1 for either 15 mm (A) or 6 hr (B) followed by determination of PGE2
levels in the cell supernatant. N = 4 per data point; * P < 0.005 and ** P
< 0.025, both vs. basal PGE2 release.
by growth-arrested mesangial cells was similar at 15 minutes and
6 hours, indicating that similar kinetics exist for both early and
late stimulation of PGE2 production by ET-1. The same findings
were observed when identical dose-response curves were per-
formed in cycling cells (data not shown). In both growth-arrested
and cycling mesangial cells the maximal stimulation of PGE2
release occurred at an ET-1 concentration of 10 nM. Lastly, ET-1
stimulation of PGE2 release was completely blocked at both 15
minutes and 6 hours by 1 M BQ123, a specific antagonist of ET-1
binding to the endothelin A receptor (Fig. 3) [22]. These data
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Fig. 3. Effect of the ET receptor subtype A antagonist, BQ123, on ET-1
stimulation of PGE2 release by cycling cultured rat mesangial cells. Cells
were pre-incubated with media alone or containing 1 M BQ123 for 15
mm followed by addition of 10 nM ET-1 for either 15 mm or 6 hr. PGE2
levels in the cell supernatants were measured at the end of the time
periods. BQ123 did not change basal PGE2 release. N = 8 per data point;
* P < 0.001 vs. basal PGE2 release. Symbols are: (E ET-1; (•) ET-1 +
BQ123.
indicate, therefore, that ET-1 elicits both rapid and prolonged
increases in PGE2 accumulation by activation of the endothelin A
receptor.
ET-1 could be stimulating prolonged PGE2 release by a number
of mechanisms. To see if increased arachidonic acid release was
the sole mechanism of ET-1-stimulated PGE2 synthesis, the
ability of ET-1 to increase cyclooxygenase activity was assessed.
Under basal conditions, PGE2 synthesis was maximal in the
presence of 10 jIM arachidonic acid, and hence this concentration
of arachidonic acid was used for all studies. As shown in Figure 4,
one to six hours of exposure to ET-1 significantly increased
mesangial cell PGE2 production in the presence of saturating
concentrations of arachidonic acid. These studies indicate, there-
fore, that prolonged ET-1 stimulation of PGE2 production is due,
at least in part, to increases in cyclooxygenase activity. It should be
noted that 15 minutes of exposure to ET-1 increased PGE2
release by mesangial cells, but did not alter cyclooxygenase activity
(Fig. 4). This suggests that the rapid increase in PGE2 release
induced by ET-1 is due primarily to increased arachidonic acid
availability.
Since the above studies indicated that ET-1 could alter cy-
clooxygenase activity, we examined the effect of ET-1 on COX-1
and COX-2 protein and mRNA levels. As illustrated in Figure 5,
incubation with ET-1 for six hours had no effect on COX-1
protein levels in mesangial cells. Similarly, incubation with ET-1
for up to six hours had no effect on COX-1 mRNA levels (Fig. 6).
In contrast, incubation with ET-1 for six hours greatly enhanced
COX-2 protein levels in mesangial cells (Fig. 5), while incubation
with ET-1 for one and six hours greatly enhanced COX-2 mRNA
levels in mesangial cells (Fig. 6). As expected, no change in
COX-2 mRNA was seen after only 15 minutes of exposure to
ET-1. These studies indicate that ET-1 causes a selective increase
in COX-2 protein and mRNA and that this effect occurs as soon
as one hour, and continues for at least six hours, after exposure to
ET-1. It should be pointed out, however, that it is not possible to
rule out an increase in COX-1 activity that is unassociated with
increased COX-1 protein levels.
In order to further confirm that ET-1 stimulation of PGE2
release was dependent, at least in part, on new RNA and protein
synthesis, the effects of actinomycin-D and cycloheximide on ET-1
action were examined. As expected, actinomycin-D or cyclohexi-
mide had no effect on mesangial cell PGE2 release after only 15
minutes exposure to ET-1 (Panel A in both Figs. 7 and 8), but
significantly reduced the response to six hours of exposure to
ET-1. Cycloheximide caused a seven- to eight-fold increase in
basal COX-2, but not COX-1, mRNA levels (Fig. 9). There was a
massive induction of COX-2 mRNA when mesangial cells were
incubated with cycloheximide and ET-1 for six hours; again,
COX-1 mRNA levels did not change. Finally, it should be noted
that neither actinomycin-D nor cycloheximide completely inhib-
ited ET-1 stimulation of PGE2 production, suggesting that the
prolonged stimulation of PGE2 synthesis by ET-1 is due in part to
increased protein synthesis and in part to activation of mecha-
nisms which are not dependent upon new protein synthesis.
The effect of dexamethasone on ET-1-stimulated PGE2 pro-
duction and cyclooxygenase subtype mRNA levels was deter-
mined since dexamethasone has been shown to inhibit prosta-
glandin synthesis in several cell types [17]. Dexamethasone had no
effect on total cell protein or cell number. As illustrated in Figure
10, dexamethasone significantly reduced basal and ET-1-stimu-
lated PGE2 release. This inhibition of ET-1-induced PGE2 syn-
thesis was, however, only partial; PGE2 release still remained
significantly above basal levels. The effect of dexamethasone on
cyclooxygenase protein and mRNA levels was also assessed. As
shown in Figure 5, dexamethasone decreased ET-1-induced
COX-2, but not COX-1, protein expression (6 hr exposure to
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Fig. 4. Effect of ET-1 on cyclooxygenase activity in growth-arrested rat
mesangial cells. Cells were incubated with media alone or containing 10 nrvi
ET-1 for 6 hr, the wells washed, 10 .tM arachidonic acid added for 15 mm,
and PGE2 levels in the cell supernatants determined. N = 12 per data
point; * P < 0.001 vs. basal. Symbols are: (0) basal; (•) ET-1.
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Fig. 5. Effect of ET-1 and dexamethasone on cyclooxygenase-1 (COX-1) and -2 (COX-2) protein levels in growth-arrested rat mesangial cells. Cells were
pre-incubated with media alone or 2 /.LM dexamethasone for 2 hr, then 10 nM ET-1 was added to half the wells for 6 hr followed by determination of
cyclooxygenase protein content by Western analysis. Lanes are as follows: 1-2 = basal; 3-4 = ET-1; 5-6 = dexamethasone; 7-9 = ET-1 + dexamethasone.
Fig. 6. Effect of ET-1 on cyclooxygenase 1(COX 1, n::) and cyclooxygenase 2(COX 2, •) mRNA in growth-arrested rat mesangial cells. Cells were
exposed to 10 nM ET-1 for 15 mm, 1 hr or 6 hr followed by extraction of
total RNA and quantitation of COX-1, COX-2, and GAPDH mRNA
using reverse transcription and polymerase chain reaction amplification. N
= 6 per data point; * P < 0.005 and ** P < 0.025, both vs. same time point
without ET-1.
ET-1). Similarly, dexamethasone lowered ET-1-stimulated
COX-2, but not COX-1, mRNA levels in mesangial cells (6 hr
exposure to ET-1; Fig. 11). As for PGE2 production, the inhibition
of COX-2 protein and mRNA levels was not complete. Hence,
dexamethasone inhibition of ET-1-induced PGE2 accumulation is
associated with a decreased COX-2, but not COX-1, protein and
mRNA levels.
Discussion
The current study demonstrates that ET-1 induces both rapid
and sustained elevations in rat mesangial cell PGE2 production.
Both the rapid and sustained responses to ET-1 are mediated by
activation of the endothelin A receptor subtype, have a similar
dose-response, and are independent of the growth state of the
cells.
ET-1 appears to stimulate mesangial cell PGE2 production by
at least two mechanisms. The first involves increasing the avail-
ability of arachidonic acid for conversion to PGE2. The rapid
effect of ET-1 on mesangial cell free arachidonic acid levels is well
characterized. Previous studies have shown that arachidonate
release increases within five minutes of exposure of mesangial
cells to ET-1 [8] and that ET-1 induces rapid increases in both
ET ActD ET+ActD
Fig. 7. Effect of actinomycin D (Act D) and ET-1 on PGE2 release by
growth-arrested rat mesangial cells. Cells were pre-incubated with 1 j.g/ml
Act D for 15 mm, followed by addition of ET-1 or media alone for 15 mm
(A) or 6 hr (B) and subsequent determination of PGE2 levels in the cell
supernatant. N = 12 per data point; * P < 0.001 vs. basal; ** P = 0.001 vs.
basal and vs. ET-1 alone.
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phospholipase A2 and C activity in mesangial cells [4, 8]. There is
also indirect evidence supporting ET-1-induced prolonged in-
creases in arachidonate availability. For example, Uchida and
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Fig. 9. Effect of cyclohe.simide (Cyclo) and ET-1 on cyclooxygenase-1
(COX-1, 2i) and .2 (COX-2, I) mRNA levels in growth-arrested rat
mesangial cells. Cells were pre-incubated with 10 sg/ml Cyclo for 15 mm,
followed by addition of ET-1 or media alone for 6 hr and subsequent
determination of COX and GAPDH mRNA using reverse transcription
and polymerase chain reaction amplification. N = 3 per data point; * p <
0.01 vs. basal; ** P < 0.005 vs. basal; #P < 0.001 vs. basal, ET-1 alone and
Cyclo alone.
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Fig. 8. Effect of cycloheximide (Cyclo) and ET-1 on PGE2 release by
growth-arrested rat mesangial cells. Cells were pre-incubated with 10 sg/ml
Cyclo for 15 mm, followed by addition of FT-i or media alone for 15 mm
(A) or 6 hr (B) and subsequent determination of PGE2 levels in the cell
supernatant. N = S per data point; * P < 0.025 vs. basal; ** P < 0.001 vs.
basal; #P < 0.005 vs. basal and P < 0.001 vs. ET-1 alone.
Ballermann reported that mesangial cells increased PGE2 produc-
tion in an ET-1-dependent manner when co-incubated with
endothelial cells for up to 24 hours, but that excess arachidonate
abolished the ability of co-culture to augment PGE2 synthetic
rates [13]. Our finding that inhibition of ET-1-induced increases in
cyclooxygenase gene transcription (with actinomycin-D) or trans-
lation (with cycloheximide) did not completely abolish ET-1-
stimulated PGE2 production suggests that the ET-1 effect can
occur, at least in part, independent of increases in protein
synthesis.
The second mechanism by which ET-1 stimulates mesangial cell
POE2 production involves increased cyclooxygenase activity. We
observed that cyclooxygenase activity was increased after one
hour, and lasted for at least six hours, of exposure to ET-1. In
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Fig. 10. Effect of d&a,nethasone (Dex) and ET-1 on PGE2 release by
growth-arrested rat mesangial cells. Cells were pre-incubated with media
alone or 2 j.LM dexamethasone for 2 hr, then 10 nsi ET-1 was added to half
the wells for 15 mm to 6 hr followed by determination of PGE2 content in
the cell supernatants. N = 12 per data point; * P < 0.001 vs. basal; #P <
0.001 vs. basal and vs. FT-i alone. Symbols are: (0) Basal; (El) FT-i; (•)
Dex; () ET-1 + Dcx.
addition, both actinomycin-D and cycloheximide reduced the
stimulatory effect of ET-1 on PGE2 production, supporting a role
for new protein synthesis. As discussed earlier, two isoforms of
cyclooxygenase have been identified, COX-1 and COX-2. Until
recently, only COX-1 was characterized; this enzyme was known
to be constitutively expressed by mesangial cells and to be only
modestly induced by a variety of cytokines [17]. The discovery of
*
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Fig. 11. Effect of dexamethasone (Dex) and ET-1 on cyclooxygenase-1
(COX-1, t) and -2 (COX-2, U) mRNA levels in growth-arrested rat
mesangial cells. Cells were pre-incubated with media alone or 2 sM
dexamethasone for 2 hr, then 10 nM ET-1 was added to half the wells for
6 hr followed by determination of COX and GAPDH mRNA in the cells.
N = 3 per data point; * P < 0.001 vs. basal; ** P < 0.001 vs. basal and P
<0.025 vs. ET-1 alone.
COX-2 generated a great deal of interest since this enzyme was
shown to be an early response gene and to be capable of being
induced to very high levels of expression [18, 19]. Indeed, the first
description of COX-2 expression by mesangial cells was very
recently published in which interleukin-1 was shown to stimulate
seven- to eight-fold increases in rat mesangial cell COX-2 expres-
sion [29]. We undertook, therefore, to determine the effect of
ET-1 on COX-1 and COX-2 gene expression. ET-1 caused a
marked increase in COX-2 protein and mRNA levels that was
present after at least six hours of exposure to the peptide. In
contrast, ET-1 had no effect on COX-1 protein or mRNA levels.
Interestingly, cycloheximide caused a marked increase in basal
and ET-1-stimulated COX-2, but not COX-1, mRNA levels,
consistent with previous reports of "superinduction" of COX-2
mRNA in mouse fibroblasts [26] and in human endothelial cells
[18]. Taken together, the demonstration of increased cyclooxyge-
nase enzyme activity and increased COX-2 protein and mRNA
levels provides strong evidence that ET-1 induction of COX-2 is
responsible, at least in part, for prolonged stimulation of mesang-
ial cell PGE2 production. It should be noted that these results
contrast with a previous study which found that exposure of
quiescent mesangial cells to 100 nM ET-1 for six hours increased
cyclooxygenase mRNA, but not activity [21]. This previous study
did not measure PGE2 production after six hours of exposure to
ET-1, so it is not possible to make direct comparisons. In addition,
the previous study did not discriminate between COX-1 and
COX-2 mRNA since COX-2 had not been characterized at that
time. As discussed above, another group reported that ET-1
increased mesangial cell PGE2 production for up to 24 hours, but
failed to detect a change in cyclooxygenase activity [13]. That
study is also not strictly comparable with ours since we examined
the effect of ET-1 for up to six hours, but not to 24 hours. It is
possible, therefore, that ET-1 induction of cyclooxygenase activity
is reduced at later time points. This is an area for further
investigation.
As mentioned earlier, dexamethasone inhibits prostaglandin
synthesis in several cell types [171. Recent studies have suggested
that this effect of dexamethasone is mediated primarily by inhibi-
tion of COX-2, but not COX-1, synthase activity. For example,
dexamethasone inhibited lipopolysaccharide-stimulated COX-2
expression in rat alveolar macrophages and in Swiss 3T3 cells, but
had no effect on COX-1 [30, 31]. In agreement with these
observations, we found that dexamethasone reduced ET-1 stimu-
lated PGE2 production and that this effect was associated with a
reduction in COX-2, but not COX-1, protein and mRNA levels.
This result contrasts with the study by Simonson and colleagues in
which dexamethasone was found to have no effect on cyclooxyge-
nase mRNA levels in quiescent mesangial cells [21]. However, for
the same reasons mentioned above (PGE2 production and COX-2
levels not measured), comparison between studies is difficult. We
also observed that dexamethasone reduced baseline PGE2 pro-
duction by mesangial cells without associated changes in COX-2
or COX-1 protein or mRNA levels. Dexamethasone has been
reported to inhibit cytokine-induced phospholipase A2 activity in
cycling mesangial cells [32, 33]; however its effects on basal
arachidonate release are not well studied. This also represents an
area for further investigation. Finally, it is highly unlikely that,
during the time course studied, the inhibitory effect of dexameth-
asone on ET-1-stimulated PGE2 accumulation was due to down-
regulation of ET receptors. Two studies have demonstrated that
dexamethasone decreases ET receptor number on endothelial
[34] and vascular smooth muscle cells [35]. Both studies, however,
failed to detect a significant decrease in ET-1 binding for up to six
hours of exposure to the steroid and only a very slight (15%)
decrease after eight to nine hours. In contrast, we observed a
marked reduction in ET-1 stimulated PGE2 accumulation after
only three hours of incubation with dexamethasone. Additionally,
after eight hours of dexamethasone exposure, ET-1-stimulated
PGE2 accumulation was reduced by 85%, much greater than
could be accounted for by even a 15% decrease in ET-1 binding.
In summary, the finding that ET-1 induces COX-2 gene expres-
sion and prolonged PGE2 synthesis in mesangial cells provides a
mechanism for long-term negative feedback regulation of ET-1
action. Further studies are needed to define the role of this
inducible form of cyclooxygenase in modifying the renal response
to ET-1 and other cytokines.
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